AGTC completes enrollment in trial of X-linked retinoschisis gene therapy – Healio
registrarjournal.com |
AGTC completes enrollment in trial of X-linked retinoschisis gene therapy
Healio The open-label, dose escalation trial will assess the safety and efficacy of the adeno-associated virus-based gene therapy through intravitreal administration in 27 patients with X-linked retinoschisis (XLRS) caused by mutations in the RS1 gene, the … AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy in Patients … Applied Genetic Technologies (AGTC) Reports Complete Enrollment of Phase 1 / 2 Clinical Study of Investigational … |
